GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apollon Formularies PLC (STU:73R) » Definitions » PB Ratio

Apollon Formularies (STU:73R) PB Ratio : 0.17 (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Apollon Formularies PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-06), Apollon Formularies's share price is €0.0005. Apollon Formularies's Book Value per Share for the quarter that ended in Jun. 2023 was €0.00. Hence, Apollon Formularies's PB Ratio of today is 0.17.

The historical rank and industry rank for Apollon Formularies's PB Ratio or its related term are showing as below:

STU:73R' s PB Ratio Range Over the Past 10 Years
Min: 0.01   Med: 0.21   Max: 1.4
Current: 0.03

During the past 11 years, Apollon Formularies's highest PB Ratio was 1.40. The lowest was 0.01. And the median was 0.21.

STU:73R's PB Ratio is ranked better than
99.79% of 953 companies
in the Drug Manufacturers industry
Industry Median: 1.91 vs STU:73R: 0.03

During the past 12 months, Apollon Formularies's average Book Value Per Share Growth Rate was -25.00% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -67.80% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 68.20% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Apollon Formularies was 393.20% per year. The lowest was -67.80% per year. And the median was 188.40% per year.

Back to Basics: PB Ratio


Apollon Formularies PB Ratio Historical Data

The historical data trend for Apollon Formularies's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apollon Formularies PB Ratio Chart

Apollon Formularies Annual Data
Trend Jun10 Jun11 Dec12 Dec13 Dec14 Dec17 Dec18 Dec19 Dec20 Dec21
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 4.76

Apollon Formularies Semi-Annual Data
Jun11 Jun12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Jun23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.27 4.76 3.10 0.17

Competitive Comparison of Apollon Formularies's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Apollon Formularies's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apollon Formularies's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Apollon Formularies's PB Ratio distribution charts can be found below:

* The bar in red indicates where Apollon Formularies's PB Ratio falls into.



Apollon Formularies PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Apollon Formularies's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2023)
=0.0005/0.003
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Apollon Formularies  (STU:73R) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Apollon Formularies PB Ratio Related Terms

Thank you for viewing the detailed overview of Apollon Formularies's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Apollon Formularies (STU:73R) Business Description

Comparable Companies
Traded in Other Exchanges
Address
6 Hope Street, Quayside House, Castletown, IMN, IM9 1AS
Apollon Formularies PLC is a London, England and Jamaican based medical cannabis pharmaceutical company specialising in research and treatment of patients with cancer and chronic pain. It is engaged in investing by seeking to acquire a direct and/or indirect interest in projects and assets in the agriculture and logistics sectors and the medicinal cannabis sector. The company focus on opportunities in Africa and Europe. It has created proprietary hybrid medical cannabis pharmaceutical strains, technology, formulations, and treatment products.

Apollon Formularies (STU:73R) Headlines

No Headlines